
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>105-272</title>
    </head>

    <body>
        <h1>
        <a href="./105_271.html" rel="external" title="prev">≪</a>
        105-272
        <a href="./105_273.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>54歳女性。152cm、48kg。高血圧、脂質異常症、深在性皮膚真菌症の治療のため処方1と処方2の薬剤を服用していた。その後、深部静脈血栓塞栓症を発症し、その治療のため処方3が追加となった。</p>
<p><img alt="" class="alignnone size-full wp-image-21180" height="240.1" loading="lazy" sizes="(max-width: 685px) 100vw, 685px" src="data:;base64,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" width="479.49999999999994"/></p>
<p>PT-INRを治療目標域に到達させるため、ワルファリン投与量の調節を試みたが、PT-INRが3.0～6.0で推移し、コントロールが困難であった。医師は患者や薬剤師と相談し、薬物動態関連遺伝子の多型を検査することにした。</p>
<h4>問272</h4>
<p>多型を検査すべき遺伝子として、適切なのはどれか。1つ選べ。</p>
<ol><li><em>CYP2C9</em></li><li><em>CYP2C19</em></li><li><em>CYP2D6</em></li><li><em>UGT1A1</em></li><li><em>NAT2</em></li></ol>
<h4>問273</h4>
<p>遺伝子多型検査の結果、ホモの変異を有することが判明し、医師は代替薬について薬剤師に相談した。医師に提案すべき抗血栓薬として最も適切なのはどれか。1つ選べ。</p>
<ol><li>アピキサバン錠</li><li>シロスタゾール錠</li><li>ダビガトランエテキシラートメタンスルホン酸塩カプセル</li><li>チクロピジン塩酸塩錠</li><li>リバーロキサバン錠</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問272：1問273：1
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問272</h4>
<p>ワルファリンの薬効に遺伝子多型が影響する薬物代謝酵素は、CYP2C9 及び、VKORC1 です。</p>
<p>以上より、正解は 1 です。</p>
<p>類題 </p>
<h4>問273</h4>
<p>ワルファリンの代替薬なので、アピキサバン、ダビガトラン、リバーロキサバンなどが考えられます。シロスタゾール、チクロピジンは「抗血小板薬」なので、不適切と考えられます。</p>
<p>ちなみに<br/>抗血小板薬と、抗凝固薬ですが、共に血をサラサラにする薬という点では共通しています。</p>
<p>血栓症の発生に関して、「動脈」では血小板が、「静脈などで血液が滞るために起こる血栓症」では凝固因子の働きが重要です。そのため、深部静脈血栓塞栓症である本問の患者に対しては、抗凝固薬であるワルファリン等が用いられていると考えられます。</p>
<p>ダビガトラン（プラザキサ）、リバーロキサバン（イグザレルト）ですが、共にイトラコナゾールとの併用が禁忌です。P-gp 阻害により、血中濃度上昇し、出血リスク上昇が知られています。また、プラザキサについては、深部静脈血栓塞栓症について、本試験時点において適用がありません。</p>
<p>従って<br/>提案すべき抗血栓薬は、アピキサバン（エリキュース）と考えられます。</p>
<p>以上より、正解は 1 です。</p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    